{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:41:00Z","timestamp":1793598060346,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016394","name":"Association Neurofibromatoses et Recklinghause","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009411","name":"Universit\u00e9 Paris-Est Cr\u00e9teil Val-de-Marne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014804","name":"Neurofibromatosis Therapeutic Acceleration Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Neurofibromatosis type 1 (NF1) is a genetic disorder that leads to the formation of cutaneous neurofibromas (cNFs), benign nerve sheath tumors that develop in the skin and significantly impact the quality of life of patients. cNF development begins with bi-allelic NF1 loss in the Schwann cell (SC) lineage, followed by the recruitment of a complex tumor microenvironment consisting of fibroblasts, immune cells, blood vessels, axons, and a dense extracellular matrix. Despite its high prevalence and clinical impact, the molecular mechanisms underlying cNF formation remain poorly understood. Here, we used an <jats:italic>Nf1<\/jats:italic> knockout (<jats:italic>Nf1-KO<\/jats:italic>) mouse model combined with immunohistochemistry and single cell transcriptomics in order to investigate the mechanisms driving cNF development. Our results showed that mutant SCs accumulate in the skin of young mice weeks prior to the onset of cNF. However, these cells remain quiescent until triggered by skin trauma, which induces their proliferation and the rapid formation of cNFs. Using a trauma-induced <jats:italic>Nf1<\/jats:italic>-KO model with scRNAseq, we designed a transcriptomic atlas of growing and mature cNFs, as well as adjacent apparently healthy skin. This analysis identified a population of non-myelinating Aquaporin1<jats:sup>high<\/jats:sup>Nestin<jats:sup>low<\/jats:sup> SCs as the likely cells of origin for cNFs. These cells overexpress genes involved in axon growth and guidance, potentially driving the abnormal innervation observed in both mouse and patient cNFs. In addition, we found that tumor SCs, along with dermal and\/or epineurial fibroblasts and pericytes, overexpress genes encoding collagen, contributing to the extensive fibrosis characteristic of cNFs. Notably, all of these cells exhibit high expression of periostin and tenascin C, key extracellular matrix components, highlighting them as novel therapeutic targets in view of cNF treatment.<\/jats:p>","DOI":"10.1186\/s40478-025-02075-z","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T09:23:50Z","timestamp":1752917030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1"],"prefix":"10.1186","volume":"13","author":[{"given":"Pernelle","family":"Pulh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Coulpier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Onfroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layna","family":"Oubrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Abou Zougheib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fertitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Topilko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"2075_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1126\/science.aax6452","volume":"365","author":"H Abdo","year":"2019","unstructured":"Abdo H, Calvo-Enrique L, Lopez JM, Song J, Zhang M-D, Usoskin D, El Manira A, Adameyko I, Hjerling-Leffler J, Ernfors P (2019) Specialized cutaneous Schwann cells initiate pain sensation. Science 365:695\u2013699. https:\/\/doi.org\/10.1126\/science.aax6452","journal-title":"Science"},{"key":"2075_CR2","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1172\/JCI99308","volume":"128","author":"DE Allard","year":"2018","unstructured":"Allard DE, Wang Y, Li JJ, Conley B, Xu EW, Sailer D, Kimpston C, Notini R, Smith C-J, Koseoglu E, Starmer J, Zeng XL, Howard JF, Hoke A, Scherer SS, Su MA (2018) Schwann cell\u2013derived Periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment. J Clin Invest 128:4727\u20134741. https:\/\/doi.org\/10.1172\/JCI99308","journal-title":"J Clin Invest"},{"key":"2075_CR3","doi-asserted-by":"publisher","first-page":"11703","DOI":"10.1038\/ncomms11703","volume":"7","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya S, Wang W, Morales-Nebreda L, Feng G, Wu M, Zhou X, Lafyatis R, Lee J, Hinchcliff M, Feghali-Bostwick C, Lakota K, Budinger GRS, Raparia K, Tamaki Z, Varga J (2016) Tenascin-C drives persistence of organ fibrosis. Nat Commun 7:11703. https:\/\/doi.org\/10.1038\/ncomms11703","journal-title":"Nat Commun"},{"key":"2075_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tins.2019.05.005","volume":"42","author":"KJ Blake","year":"2019","unstructured":"Blake KJ, Jiang XR, Chiu IM (2019) Neuronal regulation of immunity in the skin and lungs. Trends Neurosci 42:537\u2013551. https:\/\/doi.org\/10.1016\/j.tins.2019.05.005","journal-title":"Trends Neurosci"},{"key":"2075_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40478-020-01103-4","volume":"9","author":"J-P Brosseau","year":"2021","unstructured":"Brosseau J-P, Sathe AA, Wang Y, Nguyen T, Glass DA, Xing C, Le LQ (2021) Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing. Acta Neuropathol Commun 9:11. https:\/\/doi.org\/10.1186\/s40478-020-01103-4","journal-title":"Acta Neuropathol Commun"},{"key":"2075_CR6","doi-asserted-by":"publisher","unstructured":"Cai X, Han M, Lou F, Sun Y, Yin Q, Sun L, Wang Z, Li X, Zhou H, Xu Z, Wang H, Deng S, Zheng X, Zhang T, Li Q, Zhou B, Wang H (2023) Tenascin C\u2009+\u2009papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis. Nat Commun 14:2004. https:\/\/doi.org\/10.1038\/s41467-023-37798-x","DOI":"10.1038\/s41467-023-37798-x"},{"key":"2075_CR7","doi-asserted-by":"publisher","first-page":"e128881","DOI":"10.1172\/jci.insight.128881","volume":"4","author":"BH Chamseddin","year":"2019","unstructured":"Chamseddin BH, Hernandez L, Solorzano D, Vega J, Le LQ (2019) Robust surgical approach for cutaneous neurofibroma in neurofibromatosis type 1. JCI Insight 4:e128881. https:\/\/doi.org\/10.1172\/jci.insight.128881","journal-title":"JCI Insight"},{"key":"2075_CR8","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/wrr.12101","volume":"21","author":"J Ch\u00e9ret","year":"2013","unstructured":"Ch\u00e9ret J, Lebonvallet N, Carr\u00e9 J, Misery L, Le Gall-Ianotto C (2013) Role of neuropeptides, neurotrophins, and neurohormones in skin wound healing. Wound Repair Regeneration 21:772\u2013788. https:\/\/doi.org\/10.1111\/wrr.12101","journal-title":"Wound Repair Regeneration"},{"key":"2075_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2023.06.003","author":"F Coulpier","year":"2023","unstructured":"Coulpier F, Pulh P, Oubrou L, Naudet J, Fertitta L, Gregoire J-M, Bocquet A, Schmitt A-M, Wolkenstein P, Radomska Kj, Topilko P (2023) Topical delivery of MEK inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant mice. Translational Res S1931524423001056. https:\/\/doi.org\/10.1016\/j.trsl.2023.06.003","journal-title":"Translational Res S1931524423001056"},{"key":"2075_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nbt.3820","volume":"35","author":"P Di Tommaso","year":"2017","unstructured":"Di Tommaso P, Chatzou M, Floden EW, Barja PP, Palumbo E, Notredame C (2017) Nextflow enables reproducible computational workflows. Nat Biotechnol 35:316\u2013319. https:\/\/doi.org\/10.1038\/nbt.3820","journal-title":"Nat Biotechnol"},{"key":"2075_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.stemcr.2015.06.005","volume":"5","author":"A Gresset","year":"2015","unstructured":"Gresset A, Coulpier F, Gerschenfeld G, Jourdon A, Matesic G, Richard L, Vallat J-M, Charnay P, Topilko P (2015) Boundary caps give rise to neurogenic stem cells and terminal glia in the skin. Stem Cell Rep 5:278\u2013290. https:\/\/doi.org\/10.1016\/j.stemcr.2015.06.005","journal-title":"Stem Cell Rep"},{"key":"2075_CR12","unstructured":"Hynes RO Naba A overview of the Matrisome\u2014An Inventory of Extracellular Matrix Constituents and Functions"},{"key":"2075_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.stem.2020.01.012","volume":"26","author":"S Joost","year":"2020","unstructured":"Joost S, Annusver K, Jacob T, Sun X, Dalessandri T, Sivan U, Sequeira I, Sandberg R, Kasper M (2020) The molecular anatomy of mouse skin during hair growth and rest. Cell Stem Cell 26:441\u2013457e7. https:\/\/doi.org\/10.1016\/j.stem.2020.01.012","journal-title":"Cell Stem Cell"},{"key":"2075_CR14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2020.01.015","volume":"180","author":"J Kalucka","year":"2020","unstructured":"Kalucka J, De Rooij LPMH, Goveia J, Rohlenova K, Dumas SJ, Meta E, Conchinha NV, Taverna F, Teuwen L-A, Veys K, Garc\u00eda-Caballero M, Khan S, Geldhof V, Sokol L, Chen R, Treps L, Borri M, De Zeeuw P, Dubois C, Karakach TK, Falkenberg KD, Parys M, Yin X, Vinckier S, Du Y, Fenton RA, Schoonjans L, Dewerchin M, Eelen G, Thienpont B, Lin L, Bolund L, Li X, Luo Y, Carmeliet P (2020) Single-Cell transcriptome atlas of murine endothelial cells. Cell 180:764\u2013779e20. https:\/\/doi.org\/10.1016\/j.cell.2020.01.015","journal-title":"Cell"},{"key":"2075_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-981-13-6657-4_3","volume-title":"Periostin","author":"I Kii","year":"2019","unstructured":"Kii I (2019) Periostin functions as a scaffold for assembly of extracellular proteins. In: Kudo A (ed) Periostin. Springer Singapore, Singapore, pp 23\u201332"},{"key":"2075_CR16","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh P, Raychaudhuri S (2019) Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods 16:1289\u20131296. https:\/\/doi.org\/10.1038\/s41592-019-0619-0","journal-title":"Nat Methods"},{"key":"2075_CR17","doi-asserted-by":"publisher","first-page":"e0177459","DOI":"10.1371\/journal.pone.0177459","volume":"12","author":"GM Kurtzer","year":"2017","unstructured":"Kurtzer GM, Sochat V, Bauer MW (2017) Singularity: scientific containers for mobility of compute. PLoS ONE 12:e0177459. https:\/\/doi.org\/10.1371\/journal.pone.0177459","journal-title":"PLoS ONE"},{"key":"2075_CR18","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jid.2023.01.041","volume":"143","author":"I Ly","year":"2023","unstructured":"Ly I, Romo CG, Gottesman S, Kelly KM, Kornacki D, York Z, Lee SY, Rhodes SD, Staedtke V, Steensma MR, Blakeley JO, Wolkenstein P (2023) Target product profile for cutaneous neurofibromas: clinical trials to prevent, arrest, or regress cutaneous neurofibromas. J Invest Dermatology 143:1388\u20131396. https:\/\/doi.org\/10.1016\/j.jid.2023.01.041","journal-title":"J Invest Dermatology"},{"key":"2075_CR19","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1083\/jcb.107.6.2757","volume":"107","author":"EJ Mackie","year":"1988","unstructured":"Mackie EJ, Halfter W, Liverani D (1988) Induction of Tenascin in healing wounds. J Cell Biol 107:2757\u20132767. https:\/\/doi.org\/10.1083\/jcb.107.6.2757","journal-title":"J Cell Biol"},{"key":"2075_CR20","doi-asserted-by":"publisher","first-page":"107472","DOI":"10.1016\/j.celrep.2020.03.036","volume":"31","author":"SK Mishra","year":"2020","unstructured":"Mishra SK, Wheeler JJ, Pitake S, Ding H, Jiang C, Fukuyama T, Paps JS, Ralph P, Coyne J, Parkington M, DeBrecht J, Ehrhardt-Humbert LC, Cruse GP, B\u00e4umer W, Ji R-R, Ko M-C, Olivry T (2020) Periostin activation of integrin receptors on sensory neurons induces allergic itch. Cell Rep 31:107472. https:\/\/doi.org\/10.1016\/j.celrep.2020.03.036","journal-title":"Cell Rep"},{"key":"2075_CR21","doi-asserted-by":"publisher","first-page":"111933","DOI":"10.1016\/j.celrep.2022.111933","volume":"42","author":"S Nunomura","year":"2023","unstructured":"Nunomura S, Uta D, Kitajima I, Nanri Y, Matsuda K, Ejiri N, Kitajima M, Ikemitsu H, Koga M, Yamamoto S, Honda Y, Takedomi H, Andoh T, Conway SJ, Izuhara K (2023) Periostin activates distinct modules of inflammation and itching downstream of the type 2 inflammation pathway. Cell Rep 42:111933. https:\/\/doi.org\/10.1016\/j.celrep.2022.111933","journal-title":"Cell Rep"},{"key":"2075_CR22","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1007\/s00018-017-2649-z","volume":"74","author":"DN O\u2019Dwyer","year":"2017","unstructured":"O\u2019Dwyer DN, Moore BB (2017) The role of Periostin in lung fibrosis and airway remodeling. Cell Mol Life Sci 74:4305\u20134314. https:\/\/doi.org\/10.1007\/s00018-017-2649-z","journal-title":"Cell Mol Life Sci"},{"key":"2075_CR23","doi-asserted-by":"publisher","unstructured":"Ortonne N, Wolkenstein P, Blakeley JO, Korf B, Plotkin SR, Riccardi VM, Miller DC, Huson S, Peltonen J, Rosenberg A, Carroll SL, Verma SK, Mautner V, Upadhyaya M, Stemmer-Rachamimov A (2018) Cutaneous neurofibromas: current clinical and pathologic issues. Neurology 91. https:\/\/doi.org\/10.1212\/WNL.0000000000005792","DOI":"10.1212\/WNL.0000000000005792"},{"key":"2075_CR24","doi-asserted-by":"publisher","first-page":"100112","DOI":"10.1016\/j.mbplus.2022.100112","volume":"14","author":"J Ozanne","year":"2022","unstructured":"Ozanne J, Shek B, Stephen LA, Novak A, Milne E, Mclachlan G, Midwood KS, Farquharson C (2022) Tenascin-C is a driver of inflammation in the DSS model of colitis. Matrix Biology Plus 14:100112. https:\/\/doi.org\/10.1016\/j.mbplus.2022.100112","journal-title":"Matrix Biology Plus"},{"key":"2075_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-021-03580-6","volume":"594","author":"Y Pan","year":"2021","unstructured":"Pan Y, Hysinger JD, Barron T, Schindler NF, Cobb O, Guo X, Yal\u00e7\u0131n B, Anastasaki C, Mulinyawe SB, Ponnuswami A, Scheaffer S, Ma Y, Chang K-C, Xia X, Toonen JA, Lennon JJ, Gibson EM, Huguenard JR, Liau LM, Goldberg JL, Monje M, Gutmann DH (2021) NF1 mutation drives neuronal activity-dependent initiation of optic glioma. Nature 594:277\u2013282. https:\/\/doi.org\/10.1038\/s41586-021-03580-6","journal-title":"Nature"},{"key":"2075_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41422-019-0240-x","volume":"29","author":"FA Pinho-Ribeiro","year":"2019","unstructured":"Pinho-Ribeiro FA, Chiu IM (2019) Nociceptor nerves set the stage for skin immunity. Cell Res 29:877\u2013878. https:\/\/doi.org\/10.1038\/s41422-019-0240-x","journal-title":"Cell Res"},{"key":"2075_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1158\/2159-8290.CD-18-0156","volume":"9","author":"KJ Radomska","year":"2019","unstructured":"Radomska KJ, Coulpier F, Gresset A, Schmitt A, Debbiche A, Lemoine S, Wolkenstein P, Vallat J-M, Charnay P, Topilko P (2019) Cellular origin, tumor progression, and pathogenic mechanisms of cutaneous neurofibromas revealed by mice with Nf1 knockout in boundary cap cells. Cancer Discov 9:130\u2013147. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0156","journal-title":"Cancer Discov"},{"key":"2075_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","volume":"14","author":"KA Rauen","year":"2013","unstructured":"Rauen KA (2013) The rasopathies. Annu Rev Genom Hum Genet 14:355\u2013369. https:\/\/doi.org\/10.1146\/annurev-genom-091212-153523","journal-title":"Annu Rev Genom Hum Genet"},{"key":"2075_CR29","doi-asserted-by":"publisher","first-page":"eadk4946","DOI":"10.1126\/sciadv.adk4946","volume":"10","author":"KY Sarin","year":"2024","unstructured":"Sarin KY, Bradshaw M, O\u2019Mara C, Shahryari J, Kincaid J, Kempers S, Tu JH, Dhawan S, DuBois J, Wilson D, Horwath P, De Souza MP, Powala C, Kochendoerfer GG, Plotkin SR, Webster GF, Le LQ (2024) Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1. Sci Adv 10:eadk4946. https:\/\/doi.org\/10.1126\/sciadv.adk4946","journal-title":"Sci Adv"},{"key":"2075_CR30","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.jid.2023.01.042","volume":"143","author":"V Staedtke","year":"2023","unstructured":"Staedtke V, Topilko P, Le LQ, Grimes K, Largaespada DA, Cagan RL, Steensma MR, Stemmer-Rachamimov A, Blakeley JO, Rhodes SD, Ly I, Romo CG, Lee SY, Serra E (2023) Existing and developing preclinical models for neurofibromatosis type 1\u2013\u2009Related cutaneous neurofibromas. J Invest Dermatology 143:1378\u20131387. https:\/\/doi.org\/10.1016\/j.jid.2023.01.042","journal-title":"J Invest Dermatology"},{"key":"2075_CR31","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, Hao Y, Stoeckius M, Smibert P, Satija R (2019) Comprehensive integration of Single-Cell data. Cell 177:1888\u20131902e21. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031","journal-title":"Cell"},{"key":"2075_CR32","doi-asserted-by":"crossref","unstructured":"Varol C, Sagi I (2020) LOXL2 Inhibition paves the way for Macrophage-Mediated collagen degradation in liver fibrosis. Frontiers in Immunology 11","DOI":"10.3389\/fimmu.2020.00480"},{"key":"2075_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12079-022-00674-2","volume":"16","author":"Z Wang","year":"2022","unstructured":"Wang Z, An J, Zhu D, Chen H, Lin A, Kang J, Liu W, Kang X (2022) Periostin: an emerging activator of multiple signaling pathways. J Cell Commun Signal 16:515\u2013530. https:\/\/doi.org\/10.1007\/s12079-022-00674-2","journal-title":"J Cell Commun Signal"},{"key":"2075_CR34","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1051\/medsci\/200117111158","volume":"17","author":"P Wolkenstein","year":"2001","unstructured":"Wolkenstein P (2001) La neurofibromatose 1. Med Sci (Paris) 17:1158\u20131167. https:\/\/doi.org\/10.1051\/medsci\/200117111158","journal-title":"Med Sci (Paris)"},{"key":"2075_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ccr.2007.12.027","volume":"13","author":"J Wu","year":"2008","unstructured":"Wu J, Williams JP, Rizvi TA, Kordich JJ, Witte D, Meijer D, Stemmer-Rachamimov AO, Cancelas JA, Ratner N (2008) Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert Hedgehog-Expressing cells. Cancer Cell 13:105\u2013116. https:\/\/doi.org\/10.1016\/j.ccr.2007.12.027","journal-title":"Cancer Cell"},{"key":"2075_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2332\/allergolint.13-RAI-0685","volume":"63","author":"Y Yamaguchi","year":"2014","unstructured":"Yamaguchi Y (2014) Periostin in skin tissue skin-Related diseases. Allergology Int 63:161\u2013170. https:\/\/doi.org\/10.2332\/allergolint.13-RAI-0685","journal-title":"Allergology Int"},{"key":"2075_CR37","doi-asserted-by":"publisher","first-page":"jcs260244","DOI":"10.1242\/jcs.260244","volume":"135","author":"A Yilmaz","year":"2022","unstructured":"Yilmaz A, Loustau T, Salom\u00e9 N, Poilil Surendran S, Li C, Tucker RP, Izzi V, Lamba R, Koch M, Orend G (2022) Advances on the roles of tenascin-C in cancer. J Cell Sci 135:jcs260244. https:\/\/doi.org\/10.1242\/jcs.260244","journal-title":"J Cell Sci"},{"key":"2075_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ncb3090","volume":"17","author":"W Zhou","year":"2015","unstructured":"Zhou W, Ke SQ, Huang Z, Flavahan W, Fang X, Paul J, Wu L, Sloan AE, McLendon RE, Li X, Rich JN, Bao S (2015) Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol 17:170\u2013182. https:\/\/doi.org\/10.1038\/ncb3090","journal-title":"Nat Cell Biol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02075-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:37:15Z","timestamp":1757255835000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02075-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2075"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02075-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal manipulations were approved by a French Ethical Committee (10\/01\/2020, reference number APAFIS#25551-2020031115016451 v6) and were performed according to French and European Union regulations. The study was authorized by the ethical committee of the Henri-Mondor Hospital (ID RCB: 2019-A01100-57\/SI:19.09.05.52652) and all participants provided their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}